Evidence map›Paper›PMID 30051263›Full record

ReviewWorld journal of urology2018

Non-surgical urologic management of neurogenic bladder after spinal cord injury.

Paholo G Barboglio Romo, Christopher P Smith, Ashley Cox, Márcio A Averbeck, Caroline Dowling, Cleveland Beckford, Paul Manohar, Sergio Duran, Anne P Cameron

Registry-linked trialAbstract readReview
PubMed Publisher
In one paragraph

Review in World journal of urology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04924569 (Continence Care Registry), which is not on this map. Cited by 49 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed, 3 pooled it
8.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04924569 active not recruitingnot on this mapstarted 2021, after this paper: background citation

Continence Care Registry (ConCaRe™)

Typeobservational_patient_registrySponsorHollister IncorporatedRan2021 to 2030Enrolled600ConditionsNeurogenic Bladder, Non-Neurogenic Bladder
3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 3 syntheses or guidelines pooled it, 98 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Pooled it
  4. Trial
  5. Trial
  6. Review
  7. Review
  8. Article
  9. Article
  10. Observational
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 9 institutions in 6 countries.

Paholo G Barboglio RomoUniversity of Michigan, Ann Arbor, MI, USA.
Christopher P SmithBaylor College of Medicine, Houston, TX, USA.
Ashley CoxDalhousie University, Halifax, NS, Canada.
Márcio A AverbeckMoinhos de Vento Hospital, Porto Alegre, Brazil.
Caroline DowlingRoyal Melbourne Hospital, Victoria, Australia.
Cleveland BeckfordCentro Médico Nacional, Panama, Panama.
Paul ManoharMonash Health, Victoria, Australia.
Sergio DuranNational Institute of Rehabilitation, Mexico City, Mexico.
Anne P CameronUniversity of Michigan, Ann Arbor, MI, USA. annepell@med.umich.edu.
A. Alfred Taubman Health Care Center · USBaylor College of Medicine · USDalhousie University · CAHospital Moinhos de Vento · BRInstituto Nacional de Rehabilitación · MXMonash Health · AUNational Hospital · PAThe Royal Melbourne Hospital · AUUniversity of Michigan–Ann Arbor · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo review the available data on non-surgical management for neurogenic bladder in patients with spinal cord injury (SCI). Before the introduction of urinary catheters and antibiotics, neurogenic bladder was one of the main culprits for death in those patients with SCI. Currently, the management of neurogenic bladder is focused in improving quality of life and preserving renal function.

methodsA literature review was performed and therapeutic management for neurogenic bladder was divided in six sections: (1) intermittent bladder catheterization; (2) indwelling catheters; (3) condom catheter drainage; (4) reflex voiding and bladder expression with Valsalva or Credé; (5) oral drug therapy of the spinal cord injured bladder; and (6) botulinum neurotoxin (BoNT).

resultsIntermittent catheterization is recommended as the preferable method for management of neurogenic bladder in patients with SCI based on limited high-quality data. However, this may not be feasible or available to all and other alternative options include condom catheter drainage or indwelling catheters such as urethral catheters or suprapubic tube, reflex voiding, and bladder expression with Valsalva or Credé. Non-invasive medical therapies are the key to improve incontinence, urodynamic parameters, and quality of life in this population. Botulinum neurotoxin has revolutionized the management of neurogenic bladder in the last two decades decreasing the need for reconstruction or diversion.

conclusionThe Joint SIU-ICUD (Société Internationale d'Urologie) (International Consultation on Urological Diseases) International Consultation reviewed the available presented data and provided specific conclusions and recommendations for each non-surgical urologic method to address neurogenic bladder after SCI.

Indexed as

Quality of LifeCatheters, IndwellingDrainageHumansSpinal Cord InjuriesUrinary Bladder, NeurogenicUrinary CatheterizationUrinationAnticholinergicsBotulinum toxinNeurogenic bladderSelf-catheterization

Identifiers

PMID30051263
OpenAlexW2883263845

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.